Đang chuẩn bị liên kết để tải về tài liệu:
Evaluation of prophylactic dosages of Enoxaparin in non-surgical elderly patients with renal impairment
Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ
Tải xuống
Thromboprophylaxis dosing strategies using enoxaparin in elderly patients with renal disease are limited, while dose adjustments or monitoring of anti-Xa levels are recommended. We sought to evaluate the efficacy and safety of enoxaparin 20 mg versus 30 mg subcutaneously daily by comparing anti-Xa levels, thrombosis and bleeding. | Evaluation of prophylactic dosages of Enoxaparin in non-surgical elderly patients with renal impairment